PIERANTONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 906
AS - Asia 728
EU - Europa 412
SA - Sud America 137
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 13
Totale 2.334
Nazione #
US - Stati Uniti d'America 807
SG - Singapore 285
IT - Italia 154
CN - Cina 103
VN - Vietnam 101
BR - Brasile 85
HK - Hong Kong 66
CA - Canada 33
BD - Bangladesh 32
DE - Germania 31
GB - Regno Unito 28
FR - Francia 25
IN - India 24
NL - Olanda 21
PL - Polonia 17
RU - Federazione Russa 14
IQ - Iraq 13
FI - Finlandia 11
AT - Austria 9
GF - Guiana Francese 9
JP - Giappone 9
EC - Ecuador 8
ES - Italia 8
RS - Serbia 8
TR - Turchia 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
SE - Svezia 7
ZA - Sudafrica 7
AL - Albania 6
AO - Angola 6
AR - Argentina 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
GH - Ghana 6
GT - Guatemala 6
KR - Corea 6
PE - Perù 6
SA - Arabia Saudita 6
UA - Ucraina 6
YT - Mayotte 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
BW - Botswana 5
CG - Congo 5
CL - Cile 5
CO - Colombia 5
GE - Georgia 5
HU - Ungheria 5
JO - Giordania 5
KE - Kenya 5
LC - Santa Lucia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
PK - Pakistan 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BF - Burkina Faso 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
GA - Gabon 4
HT - Haiti 4
ID - Indonesia 4
MN - Mongolia 4
MX - Messico 4
MY - Malesia 4
NI - Nicaragua 4
NO - Norvegia 4
ZM - Zambia 4
AD - Andorra 3
BZ - Belize 3
CD - Congo 3
CM - Camerun 3
DJ - Gibuti 3
GN - Guinea 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IE - Irlanda 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
ML - Mali 3
NE - Niger 3
PH - Filippine 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SO - Somalia 3
SV - El Salvador 3
TH - Thailandia 3
TL - Timor Orientale 3
TZ - Tanzania 3
VC - Saint Vincent e Grenadine 3
VE - Venezuela 3
Totale 2.238
Città #
Ashburn 200
Singapore 192
San Jose 156
Santa Clara 63
Hong Kong 58
Council Bluffs 46
Ho Chi Minh City 33
Hanoi 25
New York 22
Milan 18
Los Angeles 17
Munich 15
Boardman 14
Lauterbourg 14
Rome 14
Orem 13
São Paulo 12
Beijing 11
Hefei 10
Tokyo 9
Buffalo 8
Bytom 8
Chennai 8
Atlanta 7
Montreal 7
Washington 7
Accra 6
Brooklyn 6
Dallas 6
Denver 6
Fairfield 6
Haiphong 6
Hải Dương 6
Redondo Beach 6
Sesto San Giovanni 6
Amman 5
Brasília 5
Castries 5
Cayenne 5
Chicago 5
Da Nang 5
Johannesburg 5
Luanda 5
Manchester 5
Nairobi 5
Naples 5
Padova 5
Palermo 5
Panama City 5
Phoenix 5
Turku 5
Vienna 5
Warsaw 5
Abidjan 4
Addis Ababa 4
Amsterdam 4
Auckland 4
Belgrade 4
Bologna 4
Calcinato 4
Cambridge 4
Falkenstein 4
Jeddah 4
Lappeenranta 4
Libreville 4
Lusaka 4
New Delhi 4
Nuremberg 4
Port-au-Prince 4
Porto Alegre 4
San José 4
Tbilisi 4
Tianjin 4
Ulan Bator 4
Andorra la Vella 3
Bamako 3
Beirut 3
Bishkek 3
Biên Hòa 3
Budapest 3
Bến Tre 3
Chengdu 3
Ciudad del Este 3
Conakry 3
Cosenza 3
Dublin 3
Frankfurt am Main 3
Genoa 3
Guayaquil 3
Kingstown 3
Kinshasa 3
Kuala Lumpur 3
Las Vegas 3
London 3
Maitengwe 3
Managua 3
Miami 3
Minsk 3
Paris 3
Pelotas 3
Totale 1.293
Nome #
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 250
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience 189
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting 179
Clinical relevance of molecular biomarkers in urothelial carcinomas treated with chemotherapy, immunotherapy or targeted-therapies 170
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma 164
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy 147
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial 147
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature 145
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience 144
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study 140
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 139
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations 138
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 134
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a) 133
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience 115
Totale 2.334
Categoria #
all - tutte 7.115
article - articoli 6.766
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 0 1 8 1 0 0 2 1 4
2022/20233 2 0 0 0 0 1 0 0 0 0 0 0
2023/202458 0 1 1 2 15 11 0 6 3 0 5 14
2024/2025439 0 66 14 18 41 25 10 54 4 14 57 136
2025/20261.560 80 85 198 158 175 84 224 145 166 85 112 48
2026/2027244 34 73 96 41 0 0 0 0 0 0 0 0
Totale 2.334